Production (Stage)
Avalo Therapeutics, Inc.
AVTX
$3.75
-$0.16-4.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.50% | 1,714.51% | 704.11% | 1,381.31% | 560.26% |
| Total Receivables | -- | 349.26% | -35.11% | -25.00% | -95.92% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 83.85% | 340.57% | 245.85% | 114.54% | -38.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1,450.00% | 1,800.00% | 4,000.00% | -- | -93.65% |
| Total Current Assets | 14.14% | 1,554.44% | 580.53% | 1,175.36% | 477.64% |
|
|
|||||
| Total Current Assets | 14.14% | 1,554.44% | 580.53% | 1,175.36% | 477.64% |
| Net Property, Plant & Equipment | -49.57% | -38.47% | -19.17% | -18.20% | -22.93% |
| Long-term Investments | 0.00% | 0.00% | -27.11% | -27.11% | -27.11% |
| Goodwill | 0.00% | 0.00% | -27.11% | -27.11% | -27.11% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 11.96% | 618.01% | 236.37% | 346.90% | 241.46% |
|
|
|||||
| Total Accounts Payable | -25.66% | -36.55% | 129.53% | -12.92% | -83.54% |
| Total Accrued Expenses | 22.35% | 195.97% | 42.39% | -28.29% | -49.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.49% | 5.77% | 2.61% | -96.26% | -94.46% |
| Total Finance Division Other Current Liabilities | -99.66% | -52.27% | 2,437.99% | 4,809.98% | 10,947.28% |
| Total Other Current Liabilities | -99.66% | -52.27% | 2,437.99% | 4,809.98% | 10,947.28% |
| Total Current Liabilities | -97.40% | 50.71% | 910.39% | 329.31% | 827.94% |
|
|
|||||
| Total Current Liabilities | -97.40% | 50.71% | 910.39% | 329.31% | 827.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -78.53% | -74.38% | -25.62% | -23.38% | -21.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.91% | 34.85% | 96.29% | 78.71% | 9.42% |
| Total Liabilities | -92.92% | 29.30% | 419.53% | 253.99% | 428.95% |
|
|
|||||
| Common Stock & APIC | 47.15% | 46.97% | 4.20% | 9.40% | 11.83% |
| Retained Earnings | 16.00% | -10.48% | -2.43% | -11.26% | -45.46% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 208.95% | 1,721.36% | 43.42% | -95.26% | -1,695.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 208.95% | 1,721.36% | 43.42% | -95.26% | -1,695.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 221.30% | 1,721.36% | 54.71% | 69.13% | -1,512.97% |
|
|
|||||